Document is current
Any future updates will be listed below
-
Authors
Harm, Tobias
Lahu, Shqipdona
Mayer, Katharina
Rath, Dominik
Geisler, Tobias
Müller, Karin Anne Lydia
Janisch, Marion
Adler, Kristin
Münch, Götz
Massberg, Steffen
Kastrati, Adnan
Gawaz, Meinrad Paul https://orcid.org/0000-0003-1124-9592
-
Funding
Funding for this research was provided by:
Deutsches Zentrum für Herz-Kreislaufforschung
Deutsches Herzzentrum München
Bundesministerium für Bildung und Forschung
advanceCOR GmbH
Universitätsklinikum Tübingen
- License Information
-
More Information
Article History
Received: 23 November 2024
Accepted: 21 April 2025
First Online: 21 May 2025
Declarations
:
: The authors declare no conflict of interest related to this work. The initial study (Intracoronary Stenting and Antithrombotic Regimen: Lesion Platelet Adhesion as Selective Target of Endovenous Revacept in Patients With Chronic Coronary Syndromes Undergoing Percutaneous Coronary Intervention) was funded by the German Center for Cardiovascular Research (DZHK), Deutsches Herzzentrum München, Federal Ministry of Education and Research (BMBF), and advanceCOR GmbH (the manufacturer of Revacept, patent PCT/EP2018/067952). Tobias Harm receives research funding from the German Cardiac Society (DGK) Clinical Scientist Program. Götz Münch and Meinrad Paul Gawaz are co-founders of advanceCOR GmbH. Kristin Adler is an employee of advanceCOR GmbH. No other disclosures were reported.
